No abstract
We present the case of a 55-year-old female, who presented with 15 days of fever with rash, pancytopenia, and altered behavior. She was investigated for routine causes of fever with rash and multi organ dysfunction and treated for the same. As she tested negative for all routine causes of such an illness and did not show improvement to therapy, she was investigated for Crimean-Congo hemorrhagic fever and tested positive for the same. She was started on ribavirin, but eventually succumbed to her illness. This disease has rarely been reported from the Northern India and we need to have high clinical suspicion for this deadly disease so that appropriate therapy can be started in time for the patient and prophylaxis given to all inadvertently exposed.
OBJECTIVES To evaluate the utility of the lung ultrasound using the BLUE protocol as a diagnostic tool and analyze all clinical,investigational data of patients and compare the provisional diagnosis made using the lung ultrasound with the final diagnosis.METHODS An observational study to evaluate the utility of lung ultrasound using the BLUE protocol as a diagnostic tool in patients with acute respiratory failure admitted to our Respiratory Intensive Care Unit during a period of August 2014 to December 2015 where 100 patients were included in the study.Three items were assessed:lung sliding, artifacts (horizontal A lines or vertical B lines indicating interstitial syndrome), alveolar consolidation, and / or pleural effusion.Venous scan to screen for deep venous thrombosis was done wherever required.Ultrasound equipment used was GE-LOGIQe.It has both the convex and the ECHO probes.The diagnosis obtained by the thoracic ultrasonography with limited echocardiography was compared with clinical diagnosis arrived by the ICU team at the end of the hospital stay.RESULTSThe mean age of the patients was 65.1±15.08 years.While the mean age in our study was almost similar to that seen in the BLUE protocol (68 years),the difference seen in gender distribution was owed mainly to the large sample size of the previous studies.In our study, Pneumonia was observed in 34% patients with A profile plus PLAPS being the most common finding followed by B' profile and A/B profile.Exacerbations due to COPD/Asthma/ILD accounted for 32% of the total patients in our study with A profile without PLAPS being the commonest pattern on lung ultrasound in patients of COPD/Asthma followed by B profile in patients of ILD. Lung ultrasound does not diagnose COPD/Asthma exacerbations, but rather by ruling out other causes of acute respiratory failure it arrives at the possible diagnosis of COPD/Asthma exacerbations. Pulmonary odema was observed in 23% of patients with B profile without PLAPS being the commonest finding.9% patients had pneumothorax and A' profile with a posterolateral lung point was present in all the cases.Absence of sliding is not specific as it can be present in other conditions also.The presence of lung point is a very specific finding for the diagnosis of pneumothorax. Both the patients of Pulmonary embolism had A profile with deep vein thrombosis on venous scan.Regardless of the initial profile (A or B),the lower limb Doppler ultrasonography should be done. CONCLUSION Majority of our patients presenting with acute respiratory failure in the RICU were males,mostly elderly,in the age group of 60 years and above with significant comorbidities.Our study has demonstrated the excellent diagnostic yield of lung ultrasound using the BLUE protocol as a diagnostic tool for the evaluation of patients with acute respiratory failure.The results obtained in our study were similar and comparable with the studies done in developed countries and this modality can be used with ease and confidence in the evaluation of acute respiratory failure in the Indian settings by non radiologists ICU physicians
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.